Mutch DG - Search Results

1

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.

Oliver KE, Brady WE, Birrer M, Gershenson DM, Fleming G, Copeland LJ, Tewari K, Argenta PA, Mannel RS, Secord AA, Stephan JM, Mutch DG, Stehman FB, Muggia FM, Rose PG, Armstrong DK, Bookman MA, Burger RA, Farley JH. Oliver KE, et al. Among authors: mutch dg. Gynecol Oncol. 2017 Nov;147(2):243-249. doi: 10.1016/j.ygyno.2017.08.004. Epub 2017 Aug 12. Gynecol Oncol. 2017. PMID: 28807367 Free PMC article.

2

The effects of cyclosporin A on the lysis of ovarian cancer cells by cisplatin or adriamycin.

Mutch DG, Herzog TJ, Chen CA, Collins JL. Mutch DG, et al. Gynecol Oncol. 1992 Oct;47(1):28-33. doi: 10.1016/0090-8258(92)90070-y. Gynecol Oncol. 1992. PMID: 1427396

3

Cyclosporin enhancement of cisplatin chemotherapy in patients with refractory gynecologic cancer. A Gynecologic Oncology Group Study.

Manetta A, Boyle J, Berman ML, DiSaia PJ, Lentz S, Liao SY, Mutch D, Slater L. Manetta A, et al. Cancer. 1994 Jan 1;73(1):196-9. doi: 10.1002/1097-0142(19940101)73:1<196::aid-cncr2820730134>3.0.co;2-f. Cancer. 1994. PMID: 8275425 Clinical Trial.

4

Correlates of length of stay in gynecologic oncology patients undergoing inpatient surgery.

Massad LS, Vogler G, Herzog TJ, Mutch DG. Massad LS, et al. Among authors: mutch dg. Gynecol Oncol. 1993 Nov;51(2):214-8. doi: 10.1006/gyno.1993.1275. Gynecol Oncol. 1993. PMID: 8276297

5

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study.

Ball HG, Blessing JA, Lentz SS, Mutch DG. Ball HG, et al. Among authors: mutch dg. Gynecol Oncol. 1996 Aug;62(2):278-81. doi: 10.1006/gyno.1996.0227. Gynecol Oncol. 1996. PMID: 8751561 Clinical Trial.

6

Topotecan in platinum- and paclitaxel-resistant ovarian cancer.

Swisher EM, Mutch DG, Rader JS, Elbendary A, Herzog TJ. Swisher EM, et al. Among authors: mutch dg. Gynecol Oncol. 1997 Sep;66(3):480-6. doi: 10.1006/gyno.1997.4787. Gynecol Oncol. 1997. PMID: 9299264 Clinical Trial.

7

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG. Morris M, et al. Among authors: mutch dg. N Engl J Med. 1999 Apr 15;340(15):1137-43. doi: 10.1056/NEJM199904153401501. N Engl J Med. 1999. PMID: 10202164 Free article. Clinical Trial.

8

Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies.

Cohn DE, Mutch DG, Rader JS, Farrell M, Awantang R, Herzog TJ. Cohn DE, et al. Among authors: mutch dg. Gynecol Oncol. 2001 Dec;83(3):533-6. doi: 10.1006/gyno.2001.6433. Gynecol Oncol. 2001. PMID: 11733967

9

Surgical management of ovarian cancer.

Mutch DG. Mutch DG. Semin Oncol. 2002 Feb;29(1 Suppl 1):3-8. doi: 10.1053/sonc.2002.31589. Semin Oncol. 2002. PMID: 11840413 Review.

10

Use of complementary and alternative medicine among women with gynecologic cancers.

Swisher EM, Cohn DE, Goff BA, Parham J, Herzog TJ, Rader JS, Mutch DG. Swisher EM, et al. Among authors: mutch dg. Gynecol Oncol. 2002 Mar;84(3):363-7. doi: 10.1006/gyno.2001.6515. Gynecol Oncol. 2002. PMID: 11855870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters